Thermo Fisher Scientific Inc TMO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Thermo Fisher Scientific on Track for Record High Close — Data Talk
-
Fortrea Reinstates Knoblauch as CFO After Legal Dispute With Former Employer
-
There are six stocks that hedge funds and mutual funds are both overweight - and SpaceX is one
-
Thermo Fisher Up 10%, On Pace For Largest Percent Increase Since March 2020 — Data Talk
-
Thermo Fisher Profit, Sales Rise
-
Arcturus Therapeutics Shares Rise on Plans to Work with Thermo Fisher Scientific on Cystic Fibrosis Drug
-
Thermo Fisher Scientific on Pace for Largest Percent Increase Since October 2025 — Data Talk
-
Thermo Fisher Expects 7% Annual Organic Revenue Growth Over Long Term
Trading Information
- Previous Close Price
- MX$11,885.00
- Day Range
- MX$11,859.90–11,859.90
- 52-Week Range
- MX$7,599.01–12,290.00
- Bid/Ask
- MX$11,516.81 / MX$12,177.59
- Shares Outstanding
- 369.75M
- Market Cap
- $4.39T
- Volume/Avg
- 100 / 214
Key Statistics
- Price/Earnings (Normalized)
- 27.66
- Price/Sales
- 5.33
- Dividend Yield (Trailing)
- 0.27%
- Dividend Yield (Forward)
- 0.28%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 2.32%
Company Profile
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Large Core
- Total Number of Employees
- 125,000
- Website
- https://www.thermofisher.com
Competitors
Valuation
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.66 | 17.23 | 27.90 |
Price/Book Value | 4.76 | 2.00 | 6.48 |
Price/Sales | 5.33 | 2.86 | 6.50 |
Price/Cash Flow | 24.31 | 13.28 | 25.27 |
Price/Earnings
TMO
MRK
A
Financial Strength
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Quick Ratio | 1.01 | 0.99 | 1.41 |
Current Ratio | 1.55 | 1.69 | 2.05 |
Interest Coverage | 5.57 | 7.22 | 16.08 |
Quick Ratio
TMO
MRK
A
Profitability
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Return on Assets (Normalized) | 8.26% | 4.75% | 13.27% |
Return on Equity (Normalized) | 17.21% | 8.32% | 24.92% |
Return on Invested Capital (Normalized) | 10.33% | 6.65% | 16.95% |
Return on Assets
TMO
MRK
A
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|HW!GmyR | LOCK|jV | $245B | |||
| Danaher Corp
DHR
| LOCK|x&qYsnY | LOCK|D% | $154B | |||
| Agilent Technologies Inc
A
| LOCK|kKYB@nzH | LOCK|LG | $48B | |||
| Waters Corp
WAT
| LOCK|qc&!$? | LOCK|B@! | $43B | |||
| IQVIA Holdings Inc
IQV
| LOCK|p!GWJ%m | LOCK|<gFx | $42B | |||
| Illumina Inc
ILMN
| LOCK|!$dPWNB | LOCK|<CWR | $40B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|G@&Rq<Y< | LOCK|mN | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|D!ThCH? | LOCK|$qcX | $31B | |||
| Labcorp Holdings Inc
LH
| LOCK|^%H^!T#r | LOCK|<qqR | $25B | |||
| Quest Diagnostics Inc
DGX
| LOCK|rg%X?g | LOCK|!Kmb | $25B |
United States